Users of the blood thinner Xarelto had higher risks of recurrent venous thromboembolism and higher risks of bleeding events than those taking Eliquis, according to the findings of a new…
A new study finds that while Eliquis could prevent dangerous blood clots in cancer patients, it also doubles their risk of suffering major bleeding events.
A new reversal agent has been approved for Xarelto and Eliquis but will only continue to be approved if postmarketing studies find no problems.
New Eliquis lawsuits are being filed in Delaware state courts, claiming that the manufacturers intentionally mislead patients and the medical community about the difficulty in stopping life-threatening bleeding events.
A small Eliquis recall has been announced after a customer found pills of the wrong dosage in a bottle of the blood thinning drug.
The U.S. District Judge recently assigned to preside over all federal Eliquis injury lawsuits has granted a motion to dismiss filed by the drug makers, which may impact dozens of…
Eliquis has passed Xarelto to become the best-selling new blood thinner on the market, only to see an increasing number of lawsuits filed over bleeding injuries as well.
An Eliquis lawsuit has been filed by a woman who had to be hospitalized due to extensive gastrointestinal bleeding.
An Eliquis lawsuit blames the bleeding death of a North Carolina woman on the manufacturers' failure to adequately notify doctors and patients of the drug's bleeding risks.
